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The objective of this study was to evaluate the eﬃcacy of connective tissue massageto improve blood circulation and intermittent
claudication symptoms in type 2 diabetic patients. A randomized, placebo-controlled trial was undertaken. Ninety-eight type 2
diabetes patients with stage I or II-a peripheral arterial disease (PAD) (Leriche-Fontaine classiﬁcation)were randomly assigned to
a massagegroup or to a placebo group treated using disconnected magnetotherapy equipment. Peripheral arterial circulation was
determined by measuring diﬀerential segmental arterial pressure, heart rate, skin temperature, oxygen saturation and skin blood
ﬂow.Measurementswere takenbefore andat30min,6 monthsand1 yearafterthe15-week treatment. After the15-week program,
the groups diﬀered (P < .05) in diﬀerential segmental arterial pressure in right lower limb (lower one-third of thigh, upper and
lowerone-third ofleg) andleftlower limb(lowerone-third ofthigh andupper andlower one-third ofleg).A signiﬁcantdiﬀerence
(P < .05) was also observed in skin blood ﬂow in digits 1 and 4 of right foot and digits 2, 4 and 5 of left foot. ANOVA results were
signiﬁcant (P < .05) for right and left foot oxygen saturation but not for heart rate and temperature. At 6 months and 1 year, the
groups diﬀered in diﬀerential segmental arterial pressure in upper third of left and right legs. Connective tissue massageimproves
blood circulation in the lower limbs of type 2 diabetic patients at stage I or II-a and may be useful to slow the progression of PAD.
1.Introduction
Peripheralarterial disease (PAD)is a commondisease world-
wide and is associated with a high rate of disability [1, 2].
Diabetes is one of the main causes of PAD. The development
of vascular complications in diabetics depends on the length
of time with the disease and their glycemia control [3]. At
endothelial level, diabetic vascular complications can lead to
luminal changes, aﬀecting ﬁbrinolysis, plasma coagulation,
platelet function, and to parietal changes in contractile and
secretory functions [4, 5]. Diabetics also have a diminished
endothelium-dependent arterial relaxation capacity, due
to self-generating changes in the generation, release, and
association of self-produced vasodilatory substances [6].
Nitric oxide-mediated vasodilation is also aﬀected, since
nitric oxide is deactivated by free radicals and advanced
glycation end products [7, 8].
Intermittent claudication (IC) is a transient ischemia
caused by the inability of the vascular system to meet
muscle metabolic requirements. It usually clinically mani-
fests as a constrictive pain in the lower leg, although this
pain can also be reported in the thigh or foot in pre-
claudication conditions [9]. The pain can appear earlier
during steep or fast walks or at low temperatures. Other
symptoms associated with IC are cold feet and mottled
hairless skin with dryness or ulcerations. IC symptoms can
remain stable, heal spontaneously, or develop into chronic
ischemia of the lower limbs. It is well documented that2 Evidence-Based Complementary and Alternative Medicine
around 5% of men and 2.5% of women aged >60 years
have IC symptoms [1]. Leriche-Fontaine established a four-
stage clinical classiﬁcation of chronic lower limb ischemia.
Stage I is characterized by atheroma plaque symptoms, but
blood vessel obstruction is incomplete and compensatory
mechanisms have developed. In stage II, pain in lower limb
muscle groups, mainly calf muscles, is triggered by walking
and eases after rest: symptoms appear after a distance of
>150m in stage II-a and after <150m in stage II-b. In stage
III, the patient experiences pain while resting that worsens
when the limb is raised; the pain is mainly localized in the
feet, which become sensitive and cold and take on a pale
or red (erythematous) appearance. In stage IV, the patient
has ulcerations and limb necrosis and ﬁnds walking diﬃcult
[10]. In stages III and IV, chronic lower limb ischemia is
mainly treated surgically by thrombectomy, embolectomy,
fasciotomy, thromboendarectomy, bypass or amputation
along with pre- and post-surgical drug treatments [11].
In stage II, treatment largely consists of diabetic control
[12], non-pharmacological methods (physiotherapy, Yoga
programs, antioxidant plants) [13–18], genetic therapy,
and/or medication [19–21]. Patients with stage I disease
receive no therapy because they show no symptoms. It is
therefore important to implement measures to detect initial
stages of PAD and to control risk factors [22]. A review of
the literature on subclinical PAD diagnosis concluded that
individuals with risk factors (obesity, cholesterol, sedentary
lifestyle, smoking, dyslipemia) and positive family history
should undergo vascular Doppler examination (to calculate
ankle/brachial index (ABI)) and arterial plethysmographic
examinations (arterial neumoplethysmography and photo-
plethysmography) [23–27].
Connectivetissuemassage (CTM) mayreducesymptoms
and improve IC by increasing blood circulation to the
musculature. This is achieved by massaging along reﬂex
lines on areas of the skin connected (at a distance) with
deep tissue and internal organs, known as Head zones
[28, 29]. The hypertonic muscle region is known as the
McKenzie zone, while tissues linked to internal organs
via nerve connections are called Dicke’s connective zones.
Stimulation of these areas generates a neuro-vegetal balance
that produces a relaxed and analgesic state in the patient
and a regulation of vasomotricity in areas distantly linked
via nerve connections. CTM always begins in areas away
from hyperalgic points in aﬀected methameric muscles to
avoid painful reactions. Loose connective tissue is stretched
and stimulated by the massage to produce a neurovegetal
balance, which skin-muscle reﬂex massage mainly achieves
via the autonomous or vegetal nervous system. The stimulus
produced at subcutaneous connective tissue level relaxes
contracted tissues and improves the circulation due to
vasodilationmediatedbythevegetalnervoussystem[30,31].
To our best knowledge, however, no speciﬁc evaluation has
been published on the eﬀects of CTM in patients with PAD.
With this background, the objective of this study was to
determine the eﬃcacy of a CTM program to improve blood
circulation and IC symptoms in the lower limb and to serve
as a preventive measure against the progression of PAD in
type 2 diabetic patients. This approach may be of special
interest for patients unable to take part in physical exercise
programs.
2.Methods
2.1. Setting and Participants. This randomized, placebo-
controlled trial initially recruited all accessible patients with
medical records on the computer database of a Health-
care District in Southern Spain who were diagnosed with
and undergoing treatment for type 2 diabetes: a total of
146 patients. Study enrolment was from September 1 to
December 20, 2005. The 146 patients underwent an initial
examination (see below), and their consent was obtained
to review their clinical records to gather clinical data,
including medication history and date of type 2 diabetes
mellitus diagnosis, deﬁned by oral glucose tolerance test of
>200mg/dL or fasting blood glucose test of >126mg/dL on
two separate occasions during the previous year.
The physical examination was conducted after >3h
without food intake and >4h without medication [32],
measuring the ABI with the patient in supine position after
a Stradness test (10% gradient treadmill at 3kmh−1 up
to maximum tolerated walking distance) [33]. An 8MHz
Doppler probe (Hadeco Smartdop SD-20) and mercury
sphygmomanometer were used for this measurement, deter-
mining systolic blood pressure (SBP) ﬁrst in the right and
left brachial arteries and then in the right and left posterior
tibial arteries. The ABI was obtained by dividing the SBP
of the posterior tibial artery in each extremity by the
SBP of the brachial artery [25, 34]. The examination also
yielded glycosylated hemoglobin and BMI values, calculated
as weight (kg) divided by height squared (m2).
Study inclusion criteria were: diagnosis of type 2
diabetes; ABI of 0.6–0.9 on post-procedural Strandness
test (declared equivalent to stages I and II-a of Leriche-
Fontaine classiﬁcation by the American Diabetes Association
and American College of Cardiology) [35]; glycosylated
hemoglobinof7–10%;ageof18–65years,andBMIof27–35.
Exclusion criteria were: PAD stage II-b or higher; peripheral
venous insuﬃciency; cardiac, renal, or hepatic insuﬃciency;
uncontrolled hypertension (SBP>165/95mmHg); central
or peripheral nervous system disorders; or myopathic or
neurologic damage that impaired mobility. These criteria
were satisﬁed by 98 patients (58 females and 40 males), who
gave their written consent to participation after being fully
informed about the study and told that they would be able
to choose the days and times of measurement and treatment
sessions. The study was approved by the ethics committees
of our university (University of Almeria) and hospital
(Andalusian Health Service). Patients were assigned to one
of two groups by using a randomized balanced (stratiﬁed)
selection process. The groups were balanced for type of
medication received and Leriche-Fontaine stage (I or II-a),
using a stratiﬁcation system that generates a sequence of
letters (from table of correlatively ordered permutations) for
each category and combination of categories. The assessor,
massage and magnotherapy therapists, and patients were not
blinded to the treatment allocation of patients. The trial wasEvidence-Based Complementary and Alternative Medicine 3
conducted between January 15, 2005 and March 30, 2008.
The participants were asked to make no signiﬁcant changes
in diet, therapy, or daily activities during the course of the
study [36].
2.2. Measurements. The data gathered for the selection
process were considered the baseline measurements. The
maximuminterval between baseline data collectionand start
of the program was one day. The same data were collected
at 30min, 6 months, and one year after the program. At
these evaluation sessions, we always took the following
measurements in the order given below:
2.2.1. Walking Impairment. This was assessed by administer-
ing a validated Walking Impairment Questionnaire for PAD
patients that contains items on diﬃculties to walk a given
distance and at a given speed during the previousmonth and
on symptoms associated with walking impairment [32]. The
degree of diﬃculty was scored as none (3 points), some (2
points), great (1 point) or as no walking activity (0 point).
The walking distance score was the sum of the following
points: 20 points for walking indoors, 50 points for walking
50 , 150 for 150 , 300 for 300 , 600 for 600 , 900 for 900 ,
and 1500 points for walking 1500 . The walking speed score
was the sum of the following points: 1.5 for walking slowly,
2 for walking at average speed, 3 for walking quickly, and
5 for running or jogging. Each distance walked is used as a
weighting factor in the estimation of the walking diﬃculty.
Walking distance scores range from 0 to 34.5 and walking
speed scores from 0 to 6.60 [32].
2.2.2. Diﬀerential Segmental Arterial Blood Pressure. This
was estimated in both lower limbs using a plethysmograph
(MOD-PGV-20, Smart-V-Link, Quermed, Madrid) at the
proximal and distal thirds of thigh and leg; values were
expressed inmmHg. Brieﬂy, a blood pressure cuﬀwas placed
on the corresponding lower limb segment, and a pressure
transducer in the plethysmograph was used to record BP
changes (for 60s) after occlusion of the venous system at
75mmHg. The diﬀerential segmental arterial pressure is the
diﬀerence between systolic and diastolic arterial pressures
[27].Figure 1showstheplethysmographyresultsforthelimb
segments.
2.2.3. Diﬀerential Voltage in Skin Blood Flow. Blood ﬂow
changes were measured on each digit of both feet by photo-
plethysmography (MOD-PGV-20, Smart-V-Link, Quermed,
Madrid), with mV/V as the unit of measurement. Photo-
plethysmography is based on the principle that the infrared
range of light-emitting energy reﬂects the blood ﬂow in
subcutaneous arteries. The source of infrared transmission
is the diode, which is placed next to the cadmium-selenium
photosensor receiver at a pressure of 5–40mmHg. Most of
the light emitted by the diode is absorbed by the tissues,
and only 5–10%reaches thesubcutaneousblood vessels. The
magnitude of light reﬂected by these blood vessels increases
with higher red blood cell density [37]. The reﬂected energy
is ampliﬁed and converted into a voltage diﬀerential. The
apparatus was calibrated such that a 1% increase in blood
ﬂow corresponded to two squares on the plethysmograph
thermographic paper [38–41]( Figure 2).
2.2.4. Heart Rate and Oxygen Saturation. These measure-
ments were taken with a pulseoxymeter (Megos 3300 Oxi-
pulso) placed on the second digit of right and left foot after
patientshadrested (insupine) for5min. Inconnectivetissue
reﬂex massage, changes in heart rate (bpm) and oxygen
saturation (%) are produced by the vasodilation produced.
2.2.5. Skin Temperature. Skin temperature (in ◦C) was
measured for 5min in the inguinal region and right and
left popliteal spaces using a thermographic scan (Emergen
dermatempt).
2.3. Intervention. The massage group received a 1-h session
of CTM twice a week for 15 weeks. The placebo group
received a 30-min session of sham magnetotherapy in the
lower back and popliteal regions (15min per zone) twice
a week for 15 weeks using disconnected equipment; these
patients were instructed on the use of the magnetotherapy
equipment and were unaware that it was switched oﬀ.
Because all patients were treated in prone position on a
massage bedwith a facehole,placebo patientswere unableto
seetheequipmentduringsham treatment.Thetherapyroom
was maintained at a temperature of 29.8–34.5◦C( O r e g o n
scientiﬁc model 299N) and relative humidity of 39–42%
(Oregon scientiﬁc model 299N).
2.3.1. Massage. The therapists applied standard therapeutic
CTM, using the Dicke approach 42. The massage protocol
consisted of reﬂex-massaging the skin with the third and
fourth ﬁngertips to stretch the subcutaneous connective
tissue to the maximum. The massage must not cause pain
or enter deep into structures under the connective tissue,
avoidingoverstimulation.Thetherapistﬂexestheelbowaway
from the body, rotates the shoulder internally and applies a
light radial twist to the wrist. The patient should experience
the massage as a “switching-oﬀ” feeling.
Before the massage, patients remained in a relaxed prone
position for 30 min. At each therapy session, the full massage
protocol was applied as follows. After an initial “base build-
up” with lumbosacral and pelvic massage strokes [42, 43],
alternate strokes from left to right were applied to the
spinal axis, always in the following order [44]: ﬁve short
curving movements from ﬁfth to ﬁrst lumbar vertebra, ﬁve
movements at angle of lumbosacral joint, ﬁve short curving
movements from intercostal proximal third to dorsal axis
and up to spinal apophysis, seven light strokes in intercostal
spaces, seven short curving movements from intercostal
proximal third to dorsal axis and up to spinal apophysis (DVI
to DVII), ﬁve transverse intercostal movements from spine
to inner edge of scapula, one deep upward movement along
inner edge of scapula, one light stroke along axillary edge of
scapula and a ﬁnal movement along anterior side of scapular
spine. The following sequence of massage strokes was then
applied to the lower limbs: three strokes at origin and4 Evidence-Based Complementary and Alternative Medicine
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Figure 1: Diﬀerential segmental arterial blood pressure in lower limbs is the diﬀerence between systolic and diastolic arterial pressures in
the segment under study. The wider the diﬀerence, the greater is the arterial blood ﬂow.
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Figure 2: Voltage diﬀerential in skin blood ﬂow is the diﬀerence
between the voltage reached at systolic versus diastolic arterial
p e a k s .T h ew i d e rt h ev o l t a g ed i ﬀerence, the greater is the supply of
arterial blood to the skin, as a consequence of vasodilation upper
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insertion of ischiotibial muscles, three short strokes on both
sides of tensor fascia latae muscle, one lateral stroke from
distal region of iliotibial band to lateral side of knee, three
long strokes in triceps surae area towards each lateral side of
popliteal space, three long strokes on foot from lateral edge
of the calf muscles to lower edge of malleolus, three short
strokes upwards from lateral edges of vastus externus and
internus towards muscle ﬁbers, two upward lateral strokes
on lateral outer side of vastus externus and lateral inner
side of vastus internus, four short strokes towards patella,
three transversal strokes from right to the left side under
tibial crest, one downward stroke from outer side of knee
to ﬁbular malleolus, ﬁve short strokes in tibioastragalar area,
ﬁve short strokes on lateral outer edge of foot towards the
plantar cushion, four short strokes on interosseous muscles
and, ﬁnally, one long stroke from calcaneus to metatarsus-
phalanx joint in plantar area. After the massage, the patient
remained in a relaxed supine position for 30min.
2.4. Statistical Analysis. SPSS statistics software (version
17.0) was used for statistical analyses. The reliability and
validity of the model was studied by analyzing residual inde-
pendence, normality, and variance homogeneity. Residual
independence was analyzed by plotting the values obtained
against residues, resulting in randomly distributed points
showing nospeciﬁctrend andthereforeverifying theresidual
independence assumption. Residual normality was studied
by using a Q-Q graph, ﬁnding the dots to be located close
to the line and therefore conﬁrming the residual normality
assumption. Variance homogeneity was tested with the
Levene test, obtaining a 95% conﬁdence level and P-value
>.05, conﬁrming variance equality. The normal distribution
of variables was determined by using the Kolmogorov-
Smirnof test, expressing continuous data as means with
standard deviation (SD) in the text and tables. Changes inEvidence-Based Complementary and Alternative Medicine 5
Assessed for eligibility (n = 146)
Randomized (n = 98)
Allocated to intervention (n = 49)
Perceived allocated intervention (n = 48)
Did not receive allocated intervention (n = 1)
Reason: Need for bed rest
Followed up at 30min, 6months and 1year
Analyzed (n = 48)
Allocated to intervention (n = 49)
Received allocated intervention (n = 46)
Did not receive allocated intervention (n = 3)
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Figure 3: Flow chart of study participation None of the 98 randomized patients withdrew because of adverse events.
variables within each group were measured using the paired
t-test for independent samples. Temporal changes in the
scores were examined using a two-way repeated measures
ANOVA (group (massage group, placebo group) × time
(baseline, 30min, 6 months, 1 year)). Treatment eﬃcacy was
analyzed by using a t-test for paired samples. Independent
t-tests were applied to baseline scores to determine whether
the random assignment to groups adequately controlled for
baseline demographic diﬀerences.
Relationships between variables at baseline and post-
treatment were assessed by calculating the Pearson correla-
tion coeﬃcients, considering a 95% (α = 0.05) conﬁdence
level.
3.Results
3.1. Participants. The 98 patients (58 women and 40 men)
in the study group had a mean age of 53.57±11.69 years
(range 41–65years). One patientdroppedoutofthe massage
group and three from the placebo group (Figure 3) due to
mandatory bed rest (n = 1) or the need to care for severely
ill relatives (n = 3). No patient withdrew from the study due
to adverse eﬀects of the intervention.
No signiﬁcant diﬀerences in baseline characteristics
were observed between the massage and placebo groups
(Figure 4).
3.2.30-MinOutcomes. At30minafterthe15-weekprogram,
mean diﬀerential segmental arterial pressure values (by
plethysmography) were signiﬁcantly (P<. 05) improved
versus baseline values (right and left leg) in the massage
group, with the greatest improvements in upper third of
the right thigh (1.69 (0.83)mmHg; P<. 035), lower third
of right thigh (2.09 (0.64)mmHg; P<. 031), upper third
of right leg (3.22 (1.15)mmHg; P<. 029), upper third of
left thigh (1.54 (0.47)mmHg; P<. 004), lower third of left
thigh (1.62 (0.94)mmHg; P<. 021), and upper third of left
leg (2.57 (1.08)mmHg; P<. 024). No signiﬁcant pressure
changes were observed in the placebo group. Signiﬁcant
diﬀerences were found between massage and placebo group
in diﬀerential arterial pressure values in the lower third of
right thigh, upper third of right leg, lower third of right
leg, lower third of left thigh, and upper third of left leg
(Table 1). Repeated-measures ANOVA showed a signiﬁcant
time × groups interaction for diﬀerential arterial pressure
values in lower third of right third (F = 8.289; P<. 03),
upper third of right leg (F = 7.321; P<. 03), lower third
of right leg (F = 11.201; P<. 04), lower third of left thigh
(F = 7.323; P<. 05), and upper third of left leg (F = 9.321;
P<. 01).
Asimilar pattern wasobservedforthe diﬀerentialvoltage
in digits. Signiﬁcant (P<. 05) improvement from baseline
in the massage group was observed in diﬀerential voltage in
right ﬁrst digit (3.10 (3.37)mV/V; P<. 014), right second6 Evidence-Based Complementary and Alternative Medicine
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Figure 4: P<. 05 between intervention and placebo groups.
digit (3.93 (2.77)mV/V; P<. 024), right fourth digit (6.50
(2.82)mV/V; P<. 017), right ﬁfth digit (6.30 (3.77)mV/V;
P<. 014), left second digit (6.27 (2.54)mV/V; P<. 022),
left fourth digit (5.36 (4.81)mV/V; P<. 003) and left ﬁfth
digit (6.58 (6.13)mV/V; P<. 001). In the placebo group,
no signiﬁcant change in diﬀerential voltage was observed
in any digit (Table 2). ANOVA showed a signiﬁcant time ×
groups interaction for diﬀerential voltage in right ﬁrst digit
(F = 7.984; P<. 03), right fourth digit (F = 8.321; P<. 01),
left second digit (F = 7.224; P<. 04), left fourth digit
(F = 6.932; P<. 05), and left ﬁfth digit (F = 8.846; P<. 01).
No signiﬁcant changes in heart rate values were observed
in either group between baseline and post-treatment
(Figure 5). In the massage group, skin temperature signiﬁ-
cantly (P<. 05) diﬀered between baseline and the end of
the 15-week treatment in right inguinal fold (35.52(0.78)◦C;
P<. 037), left inguinal fold (35.99 (0.47)◦C; P<. 048), right
popliteal space (35.82 (0.39)◦C; P<. 039), and left popliteal
space (35.13 (0.75)◦C; P<. 042). Signiﬁcant diﬀerences
werealsofound(baselineversus15wks)inoxygensaturation
values in right foot (97.92 (2.93)◦C; P<. 026) and left
foot (98.09 (2.64)◦C; P<. 008). The placebo group showedEvidence-Based Complementary and Alternative Medicine 7
Table 1: Diﬀerences between groups in diﬀerential segmental arterial pressure in lower limbs.
Variable
(mmHg)
Baseline M (SD) P value
Pre-T
30 min post-program
M (SD) P value
1st-PT
6m o n t h sM (SD) P value
2nd-PT
1y e a rM (SD) P value
3rd-PT
IG PG IG PG IG PG IG PG
UTRT 1.09
(0.44)
1.17
(0.32) .32 1.69
(0.83)
1.21
(0.76) .07 1.50
(0.49)
1.24
(0.29) .09 1.48
(0.33)
1.19
(0.41) .11
LTRT 1.49
(0.06)
1.22
(0.12) .10 2.09
(0.64)
1.15
(0.51) .03∗ 1.87
(0.55)
0.89
(0.83) .04∗ 1.56
(0.94)
1.06
(0.36) .07
UTRL 2.31
(0.97)
1.79
(0.72) .07 3.22
(1.15)
1.88
(0.67) .03∗ 2.91
(1.05)
1.87
(0.58) .04∗ 2.49
(0.61)
1.86
(0.90) .04∗
LTRL 0.90
(0.06)
0.60
(0.97) .99 1.21
(0.11)
0.57
(0.06) .05∗ 1.18
(0.99)
0.69
(0.64) .08 1.03
(0.43)
0.64
(0.96) .09
UTLT 1.05
(0.34)
1.12
(0.82) .35 1.54
(0.47)
1.09
(0.71) .08 1.31
(0.58)
1.11
(0.45) .15 1.26
(0.23)
1.08
(0.55) .23
LTLT 1.39
(0.73)
1.13
(0.79) .10 1.62
(0.94)
0.99
(1.01) .05∗ 1.54
(0.88)
0.86
(0.72) .05∗ 1.41
(0.62)
0.98
(0.34) .08
UTLL 1.66
(2.57)
1.32
(0.99) .98 2.57
(1.08)
1.33
(0.92) .01∗ 2.21
(0.83)
1.35
(0.64) .04∗ 1.98
(0.51)
1.29
(0.63) .04∗
LTLL 0.89
(0.31)
0.92
(0.87) .67 1.12
(0.57)
0.97
(0.56) .18 1.07
(0.46)
0.94
(0.38) .25 0.99
(0.712)
0.90
(0.57) .36
Values are presented as mean (SD). RMG, reﬂex massage group; PG, placebo group; 1st PT, post-treatment (30min after 15-week treatment ends); 2nd PT,
6 months post-treatment; 3rd PT, 1 year post-treatment; UTRT, upper third of right thigh; LTRT, lower third of right thigh; UTRL, upper third of right leg;
LTRL, lower third of right leg; UTLT, upper third of left thigh; LTLT, lower third of left thigh; UTLL, upper third of left leg; LTLL, lower third of left leg.
∗P < .05 was considered signiﬁcant.
Table 2: Diﬀerences between groups in diﬀerential voltage in skin blood ﬂow.
Variable
(Digits)
(mV/V)
Baseline M (SD) P value
Pre-T
30 min post-program
M (SD) P value
1a-PT
6m o n t h sM (SD) P value
2a-PT
1y e a rM (SD) P value
3a-PT
IG PG IG PG IG PG IG PG
Right ﬁrst 2.19
(2.60)
2.23
(4.23) .35 3.10
(3.37)
2.18
(3.89) .03∗ 3.04
(6.55)
2.29
(5.60) .04∗ 2.59
(4.13)
2.24
(4.97) .06
Right second 3.10
(1.94)
3.42
(2.35) .07 3.93
(2.77)
3.56
(2.27) .06 3.41
(4.73)
3.48
(2.11) .30 3.21
(5.03)
3.33
(3.01) .27
Right third 2.63
(0.12)
2.87
(1.45) .10 2.96
(3.19)
2.76
(2.03) .14 2.24
(5.24)
2.80
(1.63) .05 2.38
(6.04)
2.71
(1.98) .08
Right fourth 4.73
(1.08)
4.67
(2.13) .29 6.50
(2.82)
4.62
(1.99) .01∗ 5.73
(4.46)
4.58
(4.32) .03∗ 5.02
(3.12)
4.52
(3.12) .05
Right ﬁfth 5.57
(2.69)
6.01
(2.56) .06 6.30
(3.77)
6.15
(3.11) .08 6.59
(4.80)
6.23
(2.88) .06 6.01
(5.32)
6.08
(2.97) .29
Left ﬁrst 3.84
(0.37)
4.12
(1.35) .07 4.17
(2.53)
4.09
(1.41) .31 4.55
(4.32)
4.21
(1.57) .08 4.11
(5.32)
4.01
(1.22) .22
Left second 5.20
(1.50)
5.39
(3.78) .16 6.27
(2.54)
5.55
(3.88) .04∗ 6.12
(4.17)
5.45
(3.92) .04∗ 5.88
(4.01)
5.39
(3.61) .05
Left third 4.06
(2.89)
4.23
(2.57) .21 4.44
(2.31)
4.17
(2.78) .09 4.52
(2.95)
4.29
(2.65) .09 4.48
(1.12)
4.25
(2.82) .10
Left fourth 4.88
(4.03)
4.92
(4.99) .35 5.36
(4.81)
4.89
(4.83) .05∗ 5.44
(3.73)
4.98
(5.32) .04∗ 5.24
(2.39)
4.96
(5.05) .09
Left ﬁfth 4.72
(5.01)
4.51
(4.57) .12 6.58
(6.13)
4.49
(4.68) .01∗ 5.04
(4.13)
4.57
(4.08) .04∗ 4.69
(3.13)
4.52
(4.14) .13
Values are presented as mean (SD). RMG, reﬂex massage group; PG, placebo group; 1a PT, post-treatment (30min after 15-week treatment ends); 2a PT, 6
months post-treatment; 3a PT, 1 year post-treatment).
∗P < .05 was considered signiﬁcant.8 Evidence-Based Complementary and Alternative Medicine
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Figure 5: Comparisons between study groups in levels of depres-
sion, anxiety and pain. ∗P<. 05 (95% conﬁdence interval). Values
are presented as means.
no signiﬁcant diﬀerence in any variable between baseline
and 15 weeks. The massage group showed a signiﬁcantly
(P<. 05) greater improvement versus the placebo group
in temperature at right and left popliteal spaces (Figure 6).
ANOVA showed a signiﬁcant time × groups interaction for
skintemperatureatright poplitealspace(F = 5.825;P<. 04)
and left popliteal space (F = 4.139; P<. 05) and for oxygen
saturation in right foot (F = 20.034; P<. 03) and left foot
(F = 21.938; P<. 01).
The mean (SD) maximum walking distance score sig-
niﬁcantly improved between baseline and 10-min post-
treatment (20.03 (4.32) versus 26.85 (4.26); P<. 029) in
the massage group. There were also signiﬁcant diﬀerences
between groups in this score at the end of the 15-week
treatment (baseline: 20.03 (4.32) versus 21.19 (3.94), P<
.063; 15 weeks: 26.85 (4.26) versus 21.77 (3.67), P<. 034).
However, no signiﬁcant change was observed versus baseline
orbetweengroupsinrelationtothemaximumwalkingspeed
score (baseline: 3.97 (1.10) versus 3.89 (1.25), P<. 319; 15
weeks: 4.46 (0.97) versus 3.99 (1.08), P<. 087) (Figure 7).
ANOVA showed diﬀerences in maximum walking distance
score (F = 19.347; P<. 03).
Although both diﬀerential segmental arterial pressure
and heart rate responded signiﬁcantly to CTM therapy, there
were no statistically signiﬁcant correlations (Pearson corre-
lation coeﬃcient) between the increase in skin temperature
values and the decrease in heart rate values in the massage
group(r = 0.334;P = .188)orthe placebogroup (r = 0.319;
P = .721). However, there were signiﬁcant correlations in
the massage group between the increase in skin temperature
and oxygen saturation values (r = 0.346, P = .045) and
between the increase in skin temperature and diﬀerential
segmental arterial pressure values in the upper third of the
thigh (r = 0.496; P = .031), lower third of thigh (r = 0.511;
P = .027),upperthirdofleg(r = 0.436;P = .025),andlower
third of leg (r = 0.392; P = .046).
3.3. Six-Month Outcomes. At 6 months post-treatment,
diﬀerential arterial pressure remained high in the CTM in
segments with larger muscular mass, that is, lower third of
the right thigh (P<. 048), upper third of right leg (P<
.045), and upper third of left leg (P<. 039). No signiﬁcant
change (versus baseline) was observed in the placebo group.
At 6 months, the groups signiﬁcantly (P<. 05) diﬀered in
diﬀerential pressure in lower third of right thigh, upper third
of right leg, lower third of left thigh, and upper third of left
leg (Table 1). There were also statistically signiﬁcant (P<
.05) diﬀerences between the groups in diﬀerential voltage
in right ﬁrst digit, right fourth digit, left second digit, left
fourth digit, and left ﬁfth digit (Table 2). Repeated-measures
ANOVA showed a signiﬁcant time × groups interaction for
diﬀerential arterial pressure values in lower third of right
third (F = 7.321; P<. 04), upper third of right leg (F =
7.146; P<. 04), lower third of left thigh (F = 6.852; P<. 05),
and upper third of left leg (F = 7.049; P<. 04) and for
diﬀerential voltage in right ﬁrst digit (F = 8.129; P<. 04),
right fourth digit (F = 7.646; P<. 03), left second digit
(F = 8.731; P<. 04), left fourth digit (F = 8.427; P<. 04),
and left ﬁfth digit (F = 8.633; P<. 04).
In the massage group, signiﬁcant diﬀerences were found
between baseline and six months post-treatment in skin
temperature of right inguinal fold (P<. 046) and in oxygen
saturation of right (P<. 045) and left foot (.043). The
placebo group showed no signiﬁcant diﬀerence between
baseline and two months in any variable. The massage group
showed a signiﬁcantly greater improvement versus placebo
group in maximum walking distance (P<. 049) but not
in maximum walking speed (P<. 073) (Figure 7). ANOVA
analysis showed signiﬁcant diﬀerences for oxygen saturation
in right foot (F = 3.821; P<. 04) and left foot (F = 4.053;
P<. 03) and for maximum walking distance (F = 17.721;
P<. 04).
3.4. One-Year Outcomes. At the 1-year follow-up, the
improvements observed in the massage group at 6 months
largely persisted, with signiﬁcant diﬀerences versus baseline
in: diﬀerential pressure in upper third of right leg (P<. 041)
and upper third of left leg (P<. 039); diﬀerential voltage in
right ﬁrst digit (P<. 045) and left second digit (P<. 046);
and oxygen saturation in right (P<. 047) and left (P<. 049)
feet. The placebo group again showed no diﬀerences with
baseline values. The massage group showed a signiﬁcantly
greater improvement versus placebo group (P>. 05) in
diﬀerential pressure in upper third of right leg and upper
third of left leg and in oxygensaturation in both feet (Table 1
and Figure 6). No signiﬁcant changes were observed versus
baseline or between groups in maximum walking distance or
maximum speed scores (Figure 7). ANOVA analysis showed
signiﬁcant interaction for diﬀerential arterial pressure values
in upper third of right leg (F = 7.124; P<. 04) and upper
third of left leg (F = 6.993; P<. 04) and for oxygen
saturation in right foot (F = 3.747; P<. 04) and left foot
(F = 4.236; P<. 03).
4.Discussion
In a group of type 2 diabetes patients with stage I or II-a
PAD, the application of a CTM protocol (Dicke approach)Evidence-Based Complementary and Alternative Medicine 9
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Figure 6: Comparisons between study groups in skin temperature and oxygen saturation. ∗P<. 05 (95% conﬁdence interval). Values are
presented as means.
twice a week for 15 weeks increased diﬀerential segmental
pressure in leg as measured by plethysmography, improved
skin blood ﬂow as determined by photoplethysmography,
and increased pulse volume according to Doppler studies.
The improvement observed in the massage group after CTM
was in line with the results obtained by Castro et al. [43]
applying a massage protocol to healthy subjects. Massage of
the connective tissue reduces peripheral vascular resistance
at microcirculation level [28–30]. The vascular structure
facilitates the work of increasing the blood ﬂow from ter-
minal arterioles until it progressively reaches the large blood
vessels. A contribution to this ascending vasodilatation may
be made by the endothelium from ﬂattened squamous cells
on the contact surface between vessel wall and circulating
blood. These cells respond to changes in humoral conditions
in the cardiovascular system, translating these changes into
vasoactive signals that regulate the blood ﬂow [44, 45].
We measured variations in skin blood ﬂow by photo-
plethysmographybasedontechniquesstudiedbyDidieretal.
[46], Allen et al. [27]a n dB e r t i n oe ta l .[ 47], who all stressed
the usefulness of digital photoplethysmographic evaluation
at the diﬀerent Leriche-Fontaine stages of the disease. This
method allows qualitative variations in wave morphology
(diﬀerences between systolic and diastolic peaks) to be
measured before and after therapy. The presence of arterial
ischemia produces qualitative changes in curve morphology
recorded by the photoplethysmograph as a diﬀerential
voltage decrease versus the contralateral foot.
At the ﬁrst post-therapeutic evaluation (at 30min), a
slight temperature increase due to skin vasodilation was
detected, likely due to a combination of both neuronal and
localized processes [48]. Previous studies [49–51] found no
diﬀerence between high- and normal-blood pressure groups
in the internal body temperature at which vasodilation
begins.
Oxygen saturation (by pulseoxymetry) and digit ABI are
good screening tools for diagnosing and monitoring PAD in
type 2 diabetic patients [52]. One study found no signiﬁcant
improvements in oxygen saturation values in these patients
after5minoffootmassage, whichmaybetoobrieftoachieve
beneﬁts; the massage produced a downward trend in the
heart rate due to vasodilation [53]. In the present study,10 Evidence-Based Complementary and Alternative Medicine
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Figure 7: Error bars in Walking Impairment Questionnaire. RMG, reﬂex massage groups, PG, placebo group. ∗P<. 05.
heart rate values were signiﬁcantly lower versus baseline in
the massage group but not in the placebo group.
It has been reported in general terms that CTM may
c a u s ep a t i e n t ss o m ed i s c o m f o r t[ 54]. None of our patients
described any such feelings during our application of the
Dicke method. Patients were instructed to tell the therapist
immediately pain was felt, and this never proved necessary.
Nevertheless,discomfort may have goneunreported by some
patients, and it would be useful to explore this aspect in
greater depth in future studies.
4.1.StudyLimitations. Amongstudylimitations,thepatients
with type II-a PAD continued to receive their usual medi-
cation during the massage program, for ethical reasons. A
further limitation is that the therapists were not blinded to
the group to which the patients belonged, which may have
inﬂuenced outcomes.
5.Conclusion
CTM increases blood circulation in the lower limbs of type
2 diabetic patients at stage I and II-a (Leriche-Fontaine)
of the disease, with improvements in diﬀerential segmental
pressure in leg and greater skin blood ﬂow. At 30min
after this massage, the heart rate lowered and oxygen
saturation and temperature values rose, conﬁrming the role
of the parasympathetic nervous system in the eﬀects of this
treatment. CTM is a treatment option for asymptomatic
patients suspected of being in Leriche-Fontaine stage I,
that is, having the main risk factors for developing the
disease. This type of massage may also be useful to improveEvidence-Based Complementary and Alternative Medicine 11
symptoms and perhaps slow the progression of the disease in
stage II-a PAD patientswho have diﬃculties in taking part in
any kind of exercise, including walking programs.
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